Related Experiment Videos
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy
D G Fortune1, H L Richards, B Kirby
1Dermatology Centre, University of Manchester School of Medicine, Manchester M6 8HD, UK.
The British Journal of Dermatology
|April 16, 2002
Summary
A 6-week multidisciplinary Psoriasis Symptom Management Programme (PSMP) significantly reduces psoriasis severity, psychological distress, and disability. Patients experienced sustained benefits for at least six months post-intervention.
Area of Science:
- Dermatology
- Psychology
- Health Services Research
Background:
- Psoriasis significantly impacts patients' psychological and social well-being.
- Stress and distress are potential exacerbating factors in psoriasis.
- Adjunctive psychological therapies show promise in psoriasis management.
Purpose of the Study:
- To evaluate the Psoriasis Symptom Management Programme (PSMP), a 6-week multidisciplinary approach.
- To assess the PSMP's effectiveness in improving psoriasis clinical severity.
- To determine the PSMP's impact on psychological distress and disability associated with psoriasis.
Main Methods:
- A case-control study involving psoriasis patients at an outpatient specialty clinic.
- Comparison between standard psoriasis treatment alone (n=53) and standard treatment plus PSMP (n=40).
- Assessments conducted at baseline, end of the 6-week program, and 6-month follow-up.
Main Results:
- The PSMP group showed significantly greater reductions in psoriasis clinical severity compared to standard care alone (P=0.001).
- PSMP participation led to significant reductions in anxiety (P=0.001), depression (P=0.001), psoriasis-related stress (P=0.001), and disability (P=0.04).
- These improvements were sustained at both 6-week and 6-month follow-up points.
Conclusions:
- A 6-week integrated multidisciplinary approach effectively manages both physical and psychological aspects of psoriasis.
- The PSMP equips patients with techniques for sustained psoriasis control for at least six months.
- This program offers a valuable adjunct to standard psoriasis treatment, improving overall patient outcomes.